ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
188 EUR
-1.6 (-0.84%)
1ABBV gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 83 industry peers in the Biotechnology industry. There are concerns on the financial health of 1ABBV while its profitability can be described as average. 1ABBV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year 1ABBV was profitable.
- 1ABBV had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ABBV has been profitable.
- Each year in the past 5 years 1ABBV had a positive operating cash flow.
1.2 Ratios
- 1ABBV's Return On Assets of 1.75% is fine compared to the rest of the industry. 1ABBV outperforms 74.70% of its industry peers.
- With an excellent Return On Invested Capital value of 15.64%, 1ABBV belongs to the best of the industry, outperforming 90.36% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for 1ABBV is in line with the industry average of 12.74%.
- The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(15.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
- 1ABBV's Profit Margin of 3.94% is fine compared to the rest of the industry. 1ABBV outperforms 78.31% of its industry peers.
- 1ABBV's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 33.05%, 1ABBV belongs to the top of the industry, outperforming 87.95% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1ABBV has declined.
- The Gross Margin of 1ABBV (71.16%) is better than 61.45% of its industry peers.
- 1ABBV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1ABBV is creating value.
- The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
- 1ABBV has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, 1ABBV has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.39 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.39, 1ABBV is in the better half of the industry, outperforming 69.88% of the companies in the same industry.
- 1ABBV has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as 1ABBV would need 3.49 years to pay back of all of its debts.
- The Debt to FCF ratio of 1ABBV (3.49) is better than 80.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.39 |
ROIC/WACC1.88
WACC8.32%
2.3 Liquidity
- 1ABBV has a Current Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.72, 1ABBV is not doing good in the industry: 77.11% of the companies in the same industry are doing better.
- 1ABBV has a Quick Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of 1ABBV (0.60) is worse than 77.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- The earnings per share for 1ABBV have decreased strongly by -12.09% in the last year.
- The Earnings Per Share has been growing slightly by 2.51% on average over the past years.
- The Revenue has been growing slightly by 7.40% in the past year.
- Measured over the past years, 1ABBV shows a quite strong growth in Revenue. The Revenue has been growing by 11.11% on average per year.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
3.2 Future
- 1ABBV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.69% yearly.
- 1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.42% yearly.
EPS Next Y7.28%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
EPS Next 5Y13.69%
Revenue Next Year8.73%
Revenue Next 2Y9.07%
Revenue Next 3Y8.57%
Revenue Next 5Y7.42%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 23.18, 1ABBV is valued on the expensive side.
- Compared to the rest of the industry, the Price/Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 80.72% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of 1ABBV to the average of the S&P500 Index (27.54), we can say 1ABBV is valued inline with the index average.
- 1ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.08.
- Based on the Price/Forward Earnings ratio, 1ABBV is valued cheaper than 90.36% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.31. 1ABBV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.18 | ||
| Fwd PE | 15.08 |
4.2 Price Multiples
- 78.31% of the companies in the same industry are more expensive than 1ABBV, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 86.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.67 | ||
| EV/EBITDA | 15.96 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of 1ABBV may justify a higher PE ratio.
- A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 16.75% in the coming years.
PEG (NY)3.19
PEG (5Y)9.23
EPS Next 2Y19.81%
EPS Next 3Y16.75%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.09%, 1ABBV has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.76, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 97.59% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.92, 1ABBV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.09% |
5.2 History
- The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 489.69% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
- 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP489.69%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
BIT:1ABBV (1/13/2026, 7:00:00 PM)
188
-1.6 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners74.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap332.27B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts77.89
Price Target213.47 (13.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.09% |
Yearly Dividend5.32
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)7.91%
PT rev (3m)13.23%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)0.63%
EPS NY rev (1m)1.03%
EPS NY rev (3m)-11.53%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.18 | ||
| Fwd PE | 15.08 | ||
| P/S | 6.49 | ||
| P/FCF | 19.67 | ||
| P/OCF | 18.56 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.96 |
EPS(TTM)8.11
EY4.31%
EPS(NY)12.47
Fwd EY6.63%
FCF(TTM)9.56
FCFY5.08%
OCF(TTM)10.13
OCFY5.39%
SpS28.97
BVpS-1.28
TBVpS-44.96
PEG (NY)3.19
PEG (5Y)9.23
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.39 |
F-Score7
WACC8.32%
ROIC/WACC1.88
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y7.28%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
EPS Next 5Y13.69%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.73%
Revenue Next 2Y9.07%
Revenue Next 3Y8.57%
Revenue Next 5Y7.42%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year9.29%
EBIT Next 3Y15.46%
EBIT Next 5Y11.36%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
What is the valuation status of ABBVIE INC (1ABBV.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 23.18 and the Price/Book (PB) ratio is -146.53.
Can you provide the dividend sustainability for 1ABBV stock?
The dividend rating of ABBVIE INC (1ABBV.MI) is 6 / 10 and the dividend payout ratio is 489.69%.